Editas Medicine, Inc. (EDIT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.98
Day's range
$2.47

Editas Medicine Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 11.11 M $36.00 M   100.00% 11.35%
BLACKROCK, INC. 08/07/2026 10.59 M $34.31 M   14.32% 10.82%
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 8.89 M $28.80 M   100.00% 9.08%
COMMODORE CAPITAL LP 08/14/2026 8.89 M $28.80 M   100.00% 9.08%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 8.89 M $28.80 M   100.00% 9.08%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 6.14 M $19.90 M   46.07% 6.27%
PARADIGM BIOCAPITAL ADVISORS LP 08/14/2026 5.59 M $18.10 M   100.00% 5.71%
OPALEYE MANAGEMENT INC. 08/14/2026 3.86 M $12.51 M   100.41% 3.95%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 3.60 M $11.66 M   14.28% 3.68%
WOODLINE PARTNERS LP 08/14/2026 3.56 M $11.52 M   100.00% 3.63%
VIVO CAPITAL, LLC 08/14/2026 3.56 M $11.52 M   100.00% 3.63%
GORDONMD GLOBAL INVESTMENTS LP 08/14/2026 3.13 M $10.13 M   100.00% 3.19%
GOLDMAN SACHS GROUP INC 08/14/2026 2.61 M $8.47 M   367.98% 2.67%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.57 M $8.33 M   11.13% 2.62%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 2.47 M $8.00 M   -37.84% 2.52%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 2.22 M $7.20 M   100.00% 2.27%
STATE STREET CORP 08/07/2026 2.19 M $7.10 M   5.57% 2.24%
MARSHALL WACE, LLP 08/13/2026 2.04 M $6.60 M   868.72% 2.08%
D. E. SHAW & CO., INC. 08/14/2026 1.90 M $6.16 M   -2.21% 1.94%
JPMORGAN CHASE & CO 08/12/2026 1.86 M $5.96 M   -4.36% 1.90%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 1.57 M $5.09 M   14.72% 1.61%
TWO SIGMA INVESTMENTS, LP 08/14/2026 1.33 M $4.32 M   -13.95% 1.36%
SEVEN FLEET CAPITAL MANAGEMENT LP 08/17/2026 1.33 M $4.31 M   100.00% 1.36%
RAYMOND JAMES FINANCIAL INC 08/14/2026 1.32 M $4.27 M   1.94% 1.35%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 1.04 M $3.36 M   -28.72% 1.06%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 1.03 M $3.34 M   -1.93% 1.05%
MACKENZIE FINANCIAL CORP 08/13/2026 878.04 K $2.84 M   20.27% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 868.03 K $2.81 M   0.78% 0.89%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 868.03 K $2.81 M   100.00% 0.89%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 852.70 K $2.76 M   100.00% 0.87%
NORTHERN TRUST CORP 08/13/2026 819.69 K $2.66 M   10.40% 0.84%
UBS GROUP AG 08/13/2026 750.76 K $2.43 M   90.67% 0.77%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 742.95 K $2.41 M   20.99% 0.76%
NUVEEN, LLC 08/11/2026 521.21 K $1.69 M   -73.64% 0.53%
MILLENNIUM MANAGEMENT LLC 08/14/2026 499.00 K $1.62 M   100.00% 0.51%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2026 477.10 K $1.55 M   43.30% 0.49%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 469.50 K $1.52 M   140.65% 0.48%
EVERSEPT PARTNERS, LP 08/14/2026 458.81 K $1.49 M   57.71% 0.47%
CASDIN CAPITAL, LLC 08/14/2026 445.00 K $1.44 M   100.00% 0.45%
PEAK6 LLC 08/13/2026 415.44 K $1.35 M   100.00% 0.42%
DIADEMA PARTNERS LP 08/14/2026 400.00 K $1.30 M   100.00% 0.41%
GSA CAPITAL PARTNERS LLP 08/06/2026 367.15 K $1.19 M   -15.48% 0.38%
MORGAN STANLEY 08/13/2026 342.17 K $1.11 M   -16.79% 0.35%
BIT CAPITAL GMBH 08/12/2026 326.00 K $1.06 M   100.00% 0.33%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 309.40 K $1.00 M   100.00% 0.32%
LOS ANGELES CAPITAL MANAGEMENT LLC 08/13/2026 271.19 K $878.64 K   93.11% 0.28%
BANK OF NEW YORK MELLON CORP 08/06/2026 262.63 K $850.91 K   -3.65% 0.27%
BANK OF AMERICA CORP /DE/ 08/14/2026 231.83 K $751.12 K   71.89% 0.24%
LPL FINANCIAL LLC 08/07/2026 231.12 K $748.81 K   231.10% 0.24%
ERSTE ASSET MANAGEMENT GMBH 07/28/2026 230.00 K $736.00 K   100.00% 0.24%

Editas Medicine Inc institutional Ownership - FAQ's

During the previous two years, 322 institutional investors and hedge funds held shares of Editas Medicine Inc. The most heavily invested institutionals were:

TCG Crossover Management, LLC: 11.11 M

BlackRock, Inc.: 10.59 M

RA CAPITAL MANAGEMENT, L.P.: 8.89 M

ADAR1 Capital Management, LLC: 8.89 M

COMMODORE CAPITAL LP: 8.89 M

VANGUARD CAPITAL MANAGEMENT LLC: 6.14 M

122.77% of Editas Medicine Inc stock is owned by institutional investors.

Institutional investors have bought a total of 150.30 M shares in the last 24 months. This purchase volume represents approximately $348.70 M in transactions.